{"gene":"DLK1","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":1993,"finding":"Pref-1 (DLK1) is synthesized as a transmembrane protein with six tandem EGF-like repeats; constitutive expression in 3T3-L1 preadipocytes blocks down-regulation of Pref-1 and drastically inhibits adipocyte differentiation, establishing it as a negative regulator of adipogenesis.","method":"cDNA cloning, constitutive expression/overexpression in 3T3-L1 preadipocytes with differentiation assay","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function via constitutive expression with clear cellular phenotype; foundational paper replicated extensively across labs","pmids":["8500166"],"is_preprint":false},{"year":1994,"finding":"The pref-1 gene consists of five exons and four introns spanning ~7.3 kb; at least five alternatively spliced forms are produced with in-frame deletions affecting the sixth EGF-like repeat, juxtamembrane, and transmembrane domains, establishing that alternate splicing generates structural diversity in DLK1 isoforms.","method":"Genomic cloning, RT-PCR, primer extension, transient transfection reporter assay","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct genomic and cDNA characterization with functional promoter validation; replicated by subsequent studies","pmids":["7519443"],"is_preprint":false},{"year":1994,"finding":"FA1 (the circulating soluble form of DLK1) is a single-chain glycoprotein with six EGF-like repeats containing up to ten O- and N-glycosylation sites; it is 99% identical to the protein encoded by human dlk/pG2 and co-localizes with insulin in beta-cell secretory granules of the pancreas.","method":"Protein purification from amniotic fluid, amino acid sequencing, glycosylation mapping, immunohistochemistry","journal":"European journal of biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct protein sequencing and structural characterization with immunohistochemical validation","pmids":["7925474"],"is_preprint":false},{"year":1997,"finding":"Membrane-associated Pref-1 is proteolytically cleaved in the juxtamembrane region to generate a ~50 kDa soluble ectodomain and smaller 24–31 kDa products; only the two largest alternatively spliced isoforms (which retain the processing site) undergo cleavage. The purified soluble ectodomain alone is sufficient to block 3T3-L1 adipocyte differentiation, demonstrating a paracrine inhibitory mechanism.","method":"Cell-free cleavage assay, immunoprecipitation of conditioned medium, E. coli expression of ectodomain, adipogenesis inhibition assay with antibody blocking","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with purified protein plus antibody neutralization; replicated in multiple subsequent studies","pmids":["9001251"],"is_preprint":false},{"year":1998,"finding":"Transcription of the pref-1 gene is repressed by dexamethasone (glucocorticoids) as an early event during adipogenic induction; a specific -183 to -170 bp 'SAD' (suppression in adipocyte differentiation) element mediates this differentiation-dependent suppression, and an ~63 kDa nuclear protein binds this element.","method":"Nuclear run-on transcription assay, actinomycin D half-life measurement, stable transfection of 5'-deletion reporter constructs, gel mobility shift assay, UV cross-linking","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (run-on, deletion mapping, gel shift) in a single rigorous study","pmids":["9822638"],"is_preprint":false},{"year":1999,"finding":"Glucocorticoid (dexamethasone)-mediated repression of pref-1 transcription contributes to promotion of adipogenesis; antisense pref-1 expression lowers endogenous pref-1 and enhances adipose conversion at sub-threshold dexamethasone concentrations, demonstrating that pref-1 down-regulation is required for adipoconversion.","method":"Stable antisense transfection in 3T3-L1, dose-response differentiation assay, nuclear run-on, actinomycin D chase","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — antisense knockdown with functional rescue and mechanistic controls; replicated across labs","pmids":["10212243"],"is_preprint":false},{"year":2002,"finding":"Pref-1/Dlk1 knockout mice display growth retardation, obesity, blepharophimosis, skeletal malformation, and increased serum lipids; the phenotype is present only in heterozygotes with a paternally inherited null allele, confirming that Pref-1 is a paternally expressed imprinted gene required for normal development and adipose tissue homeostasis.","method":"Gene-targeted knockout mouse generation, heterozygous parental cross analysis, body composition measurement, lipid metabolite assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined phenotype and parent-of-origin genetics; foundational in vivo loss-of-function study","pmids":["12101250"],"is_preprint":false},{"year":2003,"finding":"Transgenic mice expressing the large soluble Pref-1 ectodomain (fused to human IgG Fc) in adipose tissue show substantial reduction in fat pad weight and decreased adipocyte marker expression; liver-specific expression also reduces adipose mass, demonstrating an endocrine (circulating) mode of action for soluble Pref-1 in inhibiting adipogenesis in vivo.","method":"Transgenic mouse generation with aP2 and albumin promoter-driven Pref-1/hFc, fat pad weighing, adipocyte gene expression, serum metabolite analysis","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo gain-of-function with two promoter-driven transgenic lines demonstrating endocrine mechanism","pmids":["12588883"],"is_preprint":false},{"year":2004,"finding":"Overexpression of DLK1/Pref-1 in human marrow stromal (mesenchymal stem) cells inhibits both adipocyte and osteoblast differentiation without affecting proliferation, maintaining cells in a bipotential undifferentiated state; late-stage differentiation markers are suppressed while lineage commitment markers are unaffected.","method":"Retroviral stable transduction of hMSC-TERT, cytochemical staining, FACS, real-time PCR, ex vivo calvaria organ culture bone formation assay","journal":"Journal of bone and mineral research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KD/OE with multiple differentiation readouts, single lab","pmids":["15068508"],"is_preprint":false},{"year":2004,"finding":"Ectopic DLK1 protein expression in skeletal muscle of callipyge sheep (padumnal heterozygotes, +(MAT)/CLPG(PAT)) is perfectly correlated with muscular hypertrophy; transgenic mice expressing DLK1 in skeletal muscle develop generalized muscular hypertrophy, establishing DLK1 protein as the causal agent of the callipyge phenotype.","method":"Immunohistochemistry of sheep skeletal muscle, transgenic mouse generation with skeletal muscle-specific DLK1 expression, muscle mass quantification","journal":"Current biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — correlative data in sheep plus causal transgenic mouse model with defined phenotype","pmids":["15498495"],"is_preprint":false},{"year":2005,"finding":"DLK1 expression in hematopoietic HL-60 cells inhibits differentiation and proliferation; this inhibitory effect requires the intracellular domain of DLK1, not proteolytic release of the extracellular domain, identifying a novel intracellular domain-dependent mechanism distinct from the soluble ectodomain mechanism operative in preadipocytes.","method":"Stable transfection of HL-60 cells with full-length and domain-deletion DLK1 constructs, differentiation assay, proliferation assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain deletion analysis with cellular functional readout, single lab","pmids":["15806146"],"is_preprint":false},{"year":2006,"finding":"DLK1 potentiates adipogenesis in mesenchymal C3H10T1/2 cells (in contrast to its inhibitory effect in preadipocytes); this potentiating effect requires the extracellular EGF-like domain and Notch1 expression, and is associated with altered ERK1/2 activation, demonstrating context-dependent and Notch1-dependent DLK1 action.","method":"Overexpression of full-length DLK1, EGF domain only, and intracellular domain constructs in C3H10T1/2; coculture assay; Notch1 siRNA knockdown; ERK1/2 phosphorylation western blot; adipogenesis quantification","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple domain constructs and siRNA knockdown with functional readout, single lab","pmids":["17320900"],"is_preprint":false},{"year":2007,"finding":"Soluble Pref-1 activates the MEK/ERK pathway in a time- and dose-dependent manner; ERK phosphorylation by Pref-1 is required for inhibition of adipogenesis, as MEK inhibitor PD98059 or ERK1/2 siRNA knockdown abolishes Pref-1's inhibitory effect on adipocyte differentiation (primarily by preventing PPARγ2 induction).","method":"Purified soluble Pref-1 treatment of Pref-1-null MEF, phospho-ERK western blot, MEK inhibitor (PD98059) treatment, ERK1/2 siRNA knockdown, lipid accumulation and adipocyte marker expression assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with purified protein in null cells plus pharmacological and genetic inhibition of pathway; multiple orthogonal methods","pmids":["17210639"],"is_preprint":false},{"year":2007,"finding":"Circulating FA1 (soluble DLK1) reduces total body weight, fat mass, and bone mass in mice in a dose-dependent manner when overexpressed via hydrodynamic gene transfer; serum FA1 levels are regulated by growth hormone (GH increases FA1 clearance; hypophysectomy increases FA1 ~450%; GH treatment reduces it ~40%), identifying GH as a modulator of circulating DLK1.","method":"Hydrodynamic gene transfer in mice, ELISA for FA1, DEXA body composition, bone histomorphometry, GH manipulation (hydrodynamic GH transfer, hypophysectomy)","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo gain-of-function with dose-response and hormonal manipulation, single lab","pmids":["17446189"],"is_preprint":false},{"year":2007,"finding":"DLK1 represses growth hormone (GH) promoter activity in pituitary GH3 cells; this repression requires Pit-1 binding sites in the GH promoter and is independent of DLK1's EGF-like repeats and MAP kinase-modulating activity, identifying GH as a DLK1-regulated target gene via a Pit-1-dependent transcriptional mechanism.","method":"Stable DLK1 expression in GH3 cells, GH mRNA/protein/secretion assay, GH promoter-luciferase reporter cotransfection, deletion/mutation analysis of promoter, Pit-1 cotransfection, domain deletion analysis of DLK1","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter deletion/mutation mapping with functional reporter and domain analysis, single lab","pmids":["17485162"],"is_preprint":false},{"year":2009,"finding":"Pref-1 inhibits adipocyte differentiation by upregulating Sox9 expression; Sox9 directly binds the C/EBPβ and C/EBPδ promoters to suppress their activity. Sox9 downregulation is required for adipocyte differentiation to proceed. Furthermore, by inducing Sox9, Pref-1 promotes chondrogenic induction but prevents chondrocyte maturation and osteoblast differentiation.","method":"Sox9 siRNA knockdown, Sox9 overexpression, chromatin immunoprecipitation (ChIP) of Sox9 on C/EBP promoters, Pref-1 null and transgenic mice in vivo validation, adipocyte/chondrocyte/osteoblast differentiation assays","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 1 / Strong — ChIP identifies direct Sox9 binding, siRNA knockdown, overexpression, and in vivo validation across multiple lineages in one study","pmids":["19254573"],"is_preprint":false},{"year":2009,"finding":"Pref-1 is cleaved by TACE (ADAM17/TNF-α-converting enzyme) to generate the biologically active 50 kDa soluble form; only this large soluble form (not the small soluble or transmembrane forms) is biologically active to inhibit adipogenesis.","method":"TACE inhibitor treatment, isoform-specific overexpression, adipogenesis assay","journal":"Molecular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological TACE inhibition and isoform comparison, single lab review citing prior experimental work","pmids":["19541743"],"is_preprint":false},{"year":2010,"finding":"Pref-1 directly interacts with fibronectin via its juxtamembrane domain; this interaction requires fibronectin binding to α5-integrin. Fibronectin is required for Pref-1-mediated ERK/MAPK activation, Sox9 upregulation, and inhibition of adipocyte differentiation. Pref-1 activates integrin downstream signaling molecules FAK and Rac, and ERK activation by Pref-1 is blocked by Rac knockdown or dominant-negative Rac. Pref-1 does not interact with or require Notch for its adipogenic inhibitory function.","method":"Co-immunoprecipitation of Pref-1 and fibronectin, fibronectin siRNA knockdown, RGD peptide competition, α5-integrin siRNA knockdown, dominant-negative Rac expression, FAK/Rac phosphorylation western blot, adipogenesis assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct protein interaction (Co-IP), multiple knockdowns, dominant-negative, and pathway readouts in a single rigorous study; also contains explicit negative result ruling out Notch","pmids":["20457810"],"is_preprint":false},{"year":2011,"finding":"DLK1/FA1 inhibits chondrogenic differentiation of ATDC5 cells in a dose-dependent manner at all stages (proliferation, differentiation, maturation, hypertrophic conversion); this inhibition is mediated through suppression of the PI3K/Akt pathway (not ERK1/2 or p38 MAPK), and fibronectin siRNA rescue of Akt inhibition implicates fibronectin as a mediator of DLK1/FA1-Akt signaling in chondrogenic cells.","method":"Stable overexpression and conditioned medium treatment in ATDC5 cells, purified FA1 protein addition, Akt/ERK/p38 western blot, fibronectin siRNA knockdown, cartilage nodule formation assay, collagen type II/X and aggrecan gene expression","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — purified protein plus multiple pathway inhibition readouts and siRNA, single lab","pmids":["21724852"],"is_preprint":false},{"year":2012,"finding":"DLK1 is expressed selectively in hepatic stellate cells (HSCs) in adult liver; DLK1 knockdown in activated HSCs causes suppression of necdin and Wnt, epigenetic derepression of PPARγ, and morphologic/functional reversal to quiescent cells. Anti-DLK1 antibody administration after partial hepatectomy reduces early hepatocyte proliferation and liver growth, with decreased Wnt10b, β-catenin, cyclins, CDKs, p-ERK1/2, and p-AKT.","method":"DLK1 siRNA knockdown in HSCs, anti-DLK1 antibody tail vein injection post-partial hepatectomy, HSC/hepatocyte co-culture, western blot for Wnt/β-catenin/cyclin/CDK/ERK/AKT pathway components","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro knockdown and in vivo antibody neutralization with pathway readouts, single lab","pmids":["22298767"],"is_preprint":false},{"year":2012,"finding":"C/EBPδ activates Pref-1 gene transcription in brown adipocytes through binding to the proximal Pref-1 promoter region; C/EBPδ siRNA knockdown reduces Pref-1 expression, and Pref-1 controls the thermogenic gene expression program (UCP1, PGC-1α) in brown adipose tissue.","method":"C/EBPδ siRNA knockdown, promoter-reporter assay, ChIP for C/EBPδ binding, Pref-1 mRNA measurement, Pref-1-null mouse brown adipose tissue analysis","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown, reporter assay, and null mouse validation, single lab","pmids":["22324440"],"is_preprint":false},{"year":2014,"finding":"Pref-1-marked cells are very early mesenchymal adipose precursors, prior to Zfp423 or PPARγ expression, and Pref-1+ cells are of mesenchymal (not endothelial or pericytal) origin. Ablation of Pref-1-marked cells prevents both embryonic white adipose tissue development and adult adipose expansion upon high-fat feeding, demonstrating that Pref-1+ cells are required for adipogenesis.","method":"Pref-1 promoter-rtTA transgenic mice with inducible fluorescent labeling and diphtheria toxin-mediated cell ablation, lineage tracing, embryonic and adult adipose tissue analysis, high-fat diet challenge","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic lineage tracing and inducible cell ablation with clear in vivo phenotype, multiple experimental approaches","pmids":["25088414"],"is_preprint":false},{"year":2014,"finding":"DLK1 overexpression in lung cancer cells promotes invasion through upregulation of MMP9 expression; this MMP9 upregulation depends on Notch signaling, as it is blocked by γ-secretase inhibitor (GSI) treatment, and DLK1 activates Notch signaling (NOTCH1/HES1/NICD nuclear translocation) in lung cancer cells.","method":"DLK1 overexpression and knockdown in lung cancer cell lines, transwell invasion assay, western blot and gelatin zymography for MMP9, NOTCH1/HES1 expression and NICD nuclear translocation assay, GSI treatment","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — overexpression, knockdown, and pharmacological inhibition with multiple functional readouts, single lab","pmids":["24621612"],"is_preprint":false},{"year":2014,"finding":"DLK1 overexpression causes improved glucose tolerance, reduced fat stores, pituitary IGF1 resistance, defective GH feedback regulation, increased circulatory GH, and a switch in whole-body fuel metabolism toward peripheral lipid oxidation and reduced hepatic steatosis, identifying DLK1's physiological function as shifting metabolic mode away from lipid storage.","method":"Knock-in mouse overexpressing Dlk1 from endogenous control elements, glucose tolerance test, body composition, hepatic lipid measurement, GH/IGF1 axis analysis, metabolic cage studies","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — endogenous knock-in model with comprehensive metabolic phenotyping across multiple axes","pmids":["25349437"],"is_preprint":false},{"year":2017,"finding":"A paternally inherited genomic deletion of DLK1 (including the 5' UTR, first exon, and translational start site) causes familial central precocious puberty (CPP) with undetectable serum DLK1 levels; DLK1 is expressed in mouse hypothalamus and kisspeptin neuron-derived cell lines, implicating DLK1 as a regulator of pubertal timing through the hypothalamic-pituitary-gonadal axis.","method":"Linkage analysis, whole-genome sequencing, segregation analysis, ELISA for serum DLK1, in situ hybridization and qRT-PCR in mouse hypothalamus and kisspeptin cell lines","journal":"The Journal of clinical endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — human loss-of-function genetics with serum protein measurement and hypothalamic expression validation, single study","pmids":["28324015"],"is_preprint":false},{"year":2018,"finding":"Soluble DLK1 (extracellular domain) stimulates angiogenesis by activating Notch1/Akt/eNOS/Hes-1 signaling in endothelial cells; pharmacological Notch blockade (DAPT) or Notch1 knockdown/antibody neutralization reverses DLK1-induced endothelial migration and HES-1 activation.","method":"Recombinant DLK1 extracellular domain protein treatment of endothelial cells, aortic ring sprouting assay, corneal neovascularization assay, luciferase Hes-1 reporter, DAPT treatment, Notch1 siRNA and neutralizing antibody, Akt/eNOS western blot","journal":"Angiogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — recombinant protein plus pharmacological and genetic Notch inhibition with in vitro and in vivo angiogenesis assays, single lab","pmids":["29383634"],"is_preprint":false},{"year":2018,"finding":"Sox9 inactivation in Pref-1+ early adipose precursors is required for their transition to PDGFRα+ cells that express early adipogenic markers; Sox9 maintains Pref-1+ cells in a proliferative precursor state by activating Meis1, which prevents adipogenic differentiation. Pref-1+ cells precede PDGFRα+ cells in the adipogenic pathway.","method":"Pref-1 promoter-rtTA inducible Sox9 knockout mice, fluorescent labeling and cell sorting, adipogenic marker gene expression, Meis1 overexpression and knockdown","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — inducible in vivo genetic epistasis (Pref-1-Sox9-Meis1 axis) with lineage tracing and multiple cellular readouts","pmids":["30355480"],"is_preprint":false},{"year":2019,"finding":"Loss-of-function frameshift mutations of DLK1 (p.Gly199Alafs*11, p.Val271Cysfs*14, p.Pro160Leufs*50) cause familial central precocious puberty with undetectable serum DLK1; affected women show high prevalence of metabolic abnormalities (obesity, glucose intolerance, hyperlipidemia, polycystic ovary syndrome), demonstrating DLK1 as a link between reproduction and metabolism.","method":"DNA sequencing, segregation analysis, serum DLK1 ELISA, metabolic profiling of mutation carriers vs. controls","journal":"The Journal of clinical endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — human loss-of-function genetics with serum protein assay and metabolic phenotyping, replication across three families","pmids":["30462238"],"is_preprint":false},{"year":2021,"finding":"Short hairpin RNA-mediated silencing of DLK1 in neuroblastoma cells increases cellular differentiation; high DLK1 expression correlates with a super-enhancer and robust cell surface protein expression, and DLK1-targeting antibody-drug conjugate (ADCT-701) shows potent cytotoxicity in DLK1-expressing neuroblastoma xenograft models.","method":"shRNA DLK1 knockdown in neuroblastoma cells, differentiation assay, immunofluorescence/flow cytometry/IHC for cell surface DLK1, in vivo xenograft ADC treatment","journal":"Cancer cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — shRNA loss-of-function with differentiation readout and in vivo ADC efficacy, single study","pmids":["39454577"],"is_preprint":false},{"year":2014,"finding":"Membrane-bound Dlk1 promotes myogenic differentiation (hypertrophic phenotype, higher fusion rate) in C2C12 cells, whereas soluble Dlk1 inhibits myotube formation, demonstrating that the two isoforms have opposing effects on myogenesis.","method":"Stable expression of membrane-bound vs. soluble Dlk1 isoforms in C2C12 cells, myotube formation assay, fusion rate quantification, myogenic gene expression","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific overexpression with functional differentiation readouts, single lab","pmids":["24582655"],"is_preprint":false},{"year":2021,"finding":"In the subgranular zone (SGZ) of the hippocampus, Dlk1 is expressed biallelically (loss of canonical imprinting); both parental alleles are required for normal adult hippocampal neurogenesis and stem cell behavior. Reduction in Dlk1 dosage (maternal, paternal, or biallelic mutations) triggers specific cognitive abnormalities affecting discrimination of environmental stimuli.","method":"Dlk1 mutant mouse allele-specific expression analysis in SGZ, adult neurogenesis quantification, behavioral battery (spatial learning, anxiety, discrimination tasks)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — allele-specific expression analysis and loss-of-function mouse models with cellular and behavioral phenotypes, single study","pmids":["33712542"],"is_preprint":false},{"year":2012,"finding":"In the hypothalamus, DLK1 is expressed predominantly as a soluble cleaved form; DLK1 protein is localized to somata and dendrites of arginine-vasopressin neurons in PVN, SCN, and SON and of oxytocin neurons in PVN and SON, suggesting a role in post-natal development of these neuroendocrine systems.","method":"Western blot of hypothalamus protein extracts, immunohistochemistry with co-labeling for AVP and oxytocin neuronal markers","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct protein localization by fractionation and immunohistochemistry, replicated co-labeling; no functional consequence directly tested","pmids":["22563444"],"is_preprint":false}],"current_model":"DLK1 (Pref-1/FA1) is a paternally imprinted, transmembrane EGF-repeat protein that is proteolytically cleaved by TACE/ADAM17 to generate a biologically active ~50 kDa soluble ectodomain; the soluble form acts as an autocrine/paracrine inhibitor of adipogenesis by binding fibronectin, activating integrin→FAK/Rac→MEK/ERK signaling, and upregulating the transcription factor Sox9, which in turn suppresses C/EBPβ/δ expression; Sox9 also mediates DLK1's broader inhibition of osteoblast and chondrocyte differentiation, and DLK1 maintains early Pref-1+ mesenchymal precursors in an undifferentiated state that is required for adipose tissue development; membrane-bound DLK1 can additionally signal via its intracellular domain (in hematopoietic cells) or activate Notch1 signaling (in endothelial and lung cancer cells) in context-dependent manners, and loss-of-function mutations in humans cause familial central precocious puberty with metabolic abnormalities, while ectopic DLK1 expression in skeletal muscle drives hypertrophy."},"narrative":{"mechanistic_narrative":"DLK1 (Pref-1/FA1) is a paternally imprinted transmembrane protein bearing six tandem EGF-like repeats that functions as a master negative regulator of mesenchymal precursor differentiation, governing adipose, skeletal, and broader developmental programs [PMID:8500166, PMID:12101250]. The membrane-anchored protein is cleaved by TACE/ADAM17 in its juxtamembrane region to release a biologically active ~50 kDa soluble ectodomain, and only the larger alternatively spliced isoforms that retain the cleavage site are processed and active [PMID:9001251, PMID:19541743, PMID:7519443]. This soluble form acts in a paracrine and endocrine manner to block adipogenesis in vivo [PMID:12588883]. Mechanistically, soluble Pref-1 binds fibronectin through its juxtamembrane domain in an α5-integrin-dependent fashion, activating FAK/Rac and the downstream MEK/ERK cascade required to inhibit adipocyte differentiation, independently of Notch [PMID:20457810, PMID:17210639]. This signaling upregulates the transcription factor Sox9, which directly binds and represses the C/EBPβ and C/EBPδ promoters, and Sox9 likewise mediates DLK1's inhibition of chondrocyte maturation and osteoblast differentiation [PMID:19254573]. DLK1 marks very early mesenchymal adipose precursors whose Sox9-dependent maintenance (via Meis1) holds them in an undifferentiated proliferative state required for both embryonic and adult adipose development [PMID:25088414, PMID:30355480]. Beyond fat, DLK1 reprograms systemic metabolism toward peripheral lipid oxidation and intersects the GH/IGF1 axis, repressing GH transcription via Pit-1 sites [PMID:25349437, PMID:17485162]. DLK1 also signals in context-dependent modes distinct from the canonical adipogenic pathway: its intracellular domain mediates inhibition of hematopoietic differentiation [PMID:15806146], and it can activate Notch1 signaling to drive endothelial angiogenesis and lung cancer cell invasion [PMID:29383634, PMID:24621612]. Paternally inherited loss-of-function deletions and frameshift mutations in humans cause familial central precocious puberty accompanied by metabolic abnormalities [PMID:28324015, PMID:30462238].","teleology":[{"year":1993,"claim":"Established DLK1's foundational identity and function: an unknown EGF-repeat transmembrane protein whose constitutive expression revealed it as a brake on adipocyte differentiation that must be downregulated for fat conversion.","evidence":"cDNA cloning and constitutive overexpression in 3T3-L1 preadipocytes with differentiation assays","pmids":["8500166"],"confidence":"High","gaps":["Molecular mechanism of inhibition undefined","Soluble vs membrane-bound activity not yet distinguished"]},{"year":1994,"claim":"Defined the structural diversity and circulating nature of DLK1, showing alternative splicing generates isoforms differing in the juxtamembrane/transmembrane region and that a soluble glycosylated form (FA1) circulates and co-localizes with insulin in beta-cell granules.","evidence":"Genomic cloning, RT-PCR, promoter reporter assays, and protein purification/sequencing from amniotic fluid with immunohistochemistry","pmids":["7519443","7925474"],"confidence":"High","gaps":["Functional difference between isoforms not yet tested","Significance of beta-cell localization unresolved"]},{"year":1997,"claim":"Resolved how membrane DLK1 becomes the active species: juxtamembrane proteolytic cleavage releases a ~50 kDa ectodomain sufficient on its own to block adipogenesis, defining a paracrine mechanism and explaining why only the longest splice isoforms are active.","evidence":"Cell-free cleavage assays, conditioned-medium immunoprecipitation, recombinant ectodomain expression, and antibody-blocking adipogenesis assays","pmids":["9001251"],"confidence":"High","gaps":["Identity of the cleaving protease not yet established","Receptor/binding partner for the ectodomain unknown"]},{"year":1999,"claim":"Connected hormonal control of adipogenesis to DLK1 by showing glucocorticoid-driven transcriptional repression of pref-1 (via a defined SAD promoter element) is required for adipoconversion.","evidence":"Nuclear run-on, promoter deletion reporters, gel shift/UV cross-linking, and antisense knockdown with dose-response differentiation in 3T3-L1","pmids":["9822638","10212243"],"confidence":"High","gaps":["Identity of the ~63 kDa SAD-binding factor undefined","Link between transcriptional control and protein-level signaling unmapped"]},{"year":2003,"claim":"Demonstrated DLK1 acts in vivo, both as a paracrine and endocrine factor: paternally inherited null mice show obesity and developmental defects, while transgenic soluble ectodomain delivered from fat or liver reduces adipose mass systemically.","evidence":"Imprinted knockout mice with parent-of-origin crosses and aP2/albumin promoter-driven Pref-1/hFc transgenic lines with body composition analysis","pmids":["12101250","12588883"],"confidence":"High","gaps":["Downstream signaling pathway in vivo not defined","Tissue targets of circulating ectodomain unidentified"]},{"year":2005,"claim":"Revealed that DLK1 signaling is context- and isoform-dependent, with the intracellular domain (not the released ectodomain) mediating inhibition of hematopoietic differentiation, expanding beyond the soluble paracrine paradigm.","evidence":"Domain-deletion DLK1 constructs in HL-60 cells with differentiation and proliferation assays","pmids":["15806146"],"confidence":"Medium","gaps":["Intracellular domain effectors unidentified","Single cell-line context"]},{"year":2007,"claim":"Identified MEK/ERK as the signaling node through which soluble Pref-1 blocks adipogenesis, establishing a causal kinase pathway between the ectodomain and suppression of PPARγ2.","evidence":"Purified soluble Pref-1 on null MEFs with phospho-ERK blots, MEK inhibitor, and ERK1/2 siRNA","pmids":["17210639"],"confidence":"High","gaps":["Upstream receptor linking ectodomain to MEK/ERK not yet identified","How ERK suppresses PPARγ2 not detailed"]},{"year":2009,"claim":"Defined the transcriptional output and the activating protease: Pref-1-induced Sox9 directly represses C/EBPβ/δ to block adipogenesis (and broadly inhibit osteo/chondro maturation), while TACE/ADAM17 was identified as the sheddase generating the active 50 kDa form.","evidence":"Sox9 siRNA/overexpression, ChIP on C/EBP promoters, in vivo null/transgenic validation, and TACE inhibitor with isoform comparison","pmids":["19254573","19541743"],"confidence":"High","gaps":["Mechanism coupling ERK to Sox9 induction unresolved","TACE finding from review-cited pharmacology only"]},{"year":2010,"claim":"Identified fibronectin/α5-integrin as the receptor system for soluble Pref-1, placing FAK/Rac upstream of ERK and explicitly excluding Notch from the adipogenic-inhibitory pathway.","evidence":"Co-IP of Pref-1 with fibronectin, fibronectin and α5-integrin siRNA, RGD competition, dominant-negative Rac, and FAK/Rac phospho-blots","pmids":["20457810"],"confidence":"High","gaps":["Whether a direct signaling receptor beyond integrin exists unknown","Structural basis of juxtamembrane-fibronectin binding undefined"]},{"year":2011,"claim":"Extended DLK1 signaling to chondrogenesis through a distinct effector arm, showing FA1 suppresses chondrogenic differentiation via PI3K/Akt (not ERK/p38), with fibronectin again as a mediator.","evidence":"Overexpression/conditioned medium/purified FA1 in ATDC5 cells with Akt/ERK/p38 blots and fibronectin siRNA rescue","pmids":["21724852"],"confidence":"Medium","gaps":["Cell-type basis for ERK- vs Akt-pathway choice unexplained","Single lab/cell line"]},{"year":2012,"claim":"Connected DLK1 to multiple organ systems and upstream regulation: C/EBPδ activates pref-1 in brown fat to control thermogenesis, DLK1 marks hepatic stellate cells and supports liver regeneration via Wnt, and hypothalamic DLK1 localizes to AVP/oxytocin neurons.","evidence":"C/EBPδ siRNA/ChIP and null-mouse brown fat analysis; HSC siRNA and anti-DLK1 antibody post-hepatectomy; hypothalamic fractionation and immunohistochemistry","pmids":["22324440","22298767","22563444"],"confidence":"Medium","gaps":["Signaling mechanism in each tissue incompletely defined","Functional role of neuronal DLK1 not directly tested"]},{"year":2014,"claim":"Established DLK1 as a regulator of multiple precursor lineages and systemic metabolism: it marks the earliest mesenchymal adipose precursors required for fat development, opposingly regulates myogenesis by isoform, drives muscular hypertrophy (callipyge), activates Notch in lung cancer invasion, and shifts whole-body fuel use toward lipid oxidation.","evidence":"Pref-1-rtTA lineage tracing/ablation, isoform-specific C2C12 assays, callipyge sheep IHC and transgenic mice, lung cancer overexpression with GSI, and endogenous Dlk1 knock-in metabolic phenotyping","pmids":["25088414","24582655","15498495","24621612","25349437"],"confidence":"High","gaps":["How membrane vs soluble isoform ratios are set per tissue unclear","Mechanism of Notch activation in cancer vs Notch-independence in fat unreconciled"]},{"year":2017,"claim":"Linked DLK1 to human disease, showing paternally inherited DLK1 deletions cause familial central precocious puberty with hypothalamic expression in kisspeptin neurons.","evidence":"Linkage/whole-genome sequencing, segregation, serum DLK1 ELISA, and mouse hypothalamic/kisspeptin expression analysis","pmids":["28324015"],"confidence":"Medium","gaps":["Molecular mechanism by which DLK1 sets pubertal timing undefined","Cell-autonomous role in kisspeptin neurons untested"]},{"year":2018,"claim":"Defined the Sox9-Meis1 axis maintaining adipose precursors and showed DLK1's soluble domain promotes angiogenesis via Notch1/Akt/eNOS, consolidating Sox9 as the central precursor-maintenance node and Notch as a context-specific effector.","evidence":"Inducible Sox9 knockout in Pref-1+ cells with Meis1 manipulation; recombinant DLK1 ectodomain on endothelial cells with DAPT, Notch1 siRNA/antibody, and aortic ring/corneal assays","pmids":["30355480","29383634"],"confidence":"High","gaps":["Switch between integrin and Notch signaling modes mechanistically unexplained","Endothelial study single lab"]},{"year":2019,"claim":"Confirmed and broadened the human disease link by showing DLK1 frameshift loss-of-function causes precocious puberty co-occurring with obesity, glucose intolerance and PCOS, positioning DLK1 at the reproduction-metabolism interface.","evidence":"DNA sequencing, segregation across three families, serum DLK1 ELISA, and metabolic profiling of carriers","pmids":["30462238"],"confidence":"Medium","gaps":["Causal pathway from DLK1 loss to metabolic disease unmapped","Genotype-phenotype correlation limited"]},{"year":2021,"claim":"Extended DLK1 to neural and oncologic contexts, showing biallelic (imprint-escaping) hippocampal expression supports adult neurogenesis and cognition, and that surface DLK1 is a tractable therapeutic target via antibody-drug conjugate in neuroblastoma.","evidence":"Allele-specific expression and loss-of-function mouse models with behavioral assays; shRNA knockdown and ADC (ADCT-701) xenograft efficacy in neuroblastoma","pmids":["33712542","39454577"],"confidence":"Medium","gaps":["Signaling mechanism in neurogenesis undefined","DLK1 driver vs marker role in neuroblastoma not fully resolved"]},{"year":null,"claim":"The molecular identity of the signaling receptor that transduces soluble DLK1 to MEK/ERK, and the determinants that switch DLK1 between fibronectin/integrin-dependent, intracellular-domain-dependent, and Notch-dependent modes across tissues, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No direct signaling receptor for the ectodomain identified","Rules governing tissue-specific pathway selection unknown","Mechanism linking ERK/integrin signaling to Sox9 induction undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[12,17]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,3,15]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[17]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,3,28]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[2,3,7]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[12,17,25]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[15,21,26]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[23,6]}],"complexes":[],"partners":["FN1","ITGA5","NOTCH1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P80370","full_name":"Protein delta homolog 1","aliases":["pG2"],"length_aa":383,"mass_kda":41.3,"function":"May have a role in neuroendocrine differentiation","subcellular_location":"Membrane; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P80370/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DLK1","classification":"Not Classified","n_dependent_lines":16,"n_total_lines":1208,"dependency_fraction":0.013245033112582781},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DLK1","total_profiled":1310},"omim":[{"mim_id":"621120","title":"DELTA-LIKE NONCANONICAL NOTCH LIGAND 2; DLK2","url":"https://www.omim.org/entry/621120"},{"mim_id":"619508","title":"ZINC FINGER PROTEIN 445; ZNF445","url":"https://www.omim.org/entry/619508"},{"mim_id":"618597","title":"BRAIN-ENRICHED GUANYLATE KINASE-ASSOCIATED PROTEIN; BEGAIN","url":"https://www.omim.org/entry/618597"},{"mim_id":"616376","title":"MICRO RNA 656; MIR656","url":"https://www.omim.org/entry/616376"},{"mim_id":"616358","title":"MICRO RNA 379; MIR379","url":"https://www.omim.org/entry/616358"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Golgi apparatus","reliability":"Approved"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adrenal gland","ntpm":1265.2},{"tissue":"pituitary gland","ntpm":731.7},{"tissue":"placenta","ntpm":1533.9}],"url":"https://www.proteinatlas.org/search/DLK1"},"hgnc":{"alias_symbol":["FA1","pG2","Pref-1","ZOG","Delta1"],"prev_symbol":[]},"alphafold":{"accession":"P80370","domains":[{"cath_id":"2.10.25.10","chopping":"129-171","consensus_level":"high","plddt":86.6023,"start":129,"end":171},{"cath_id":"2.10.25.10","chopping":"173-207","consensus_level":"medium","plddt":84.2163,"start":173,"end":207},{"cath_id":"2.10.25.10","chopping":"211-249","consensus_level":"medium","plddt":81.3544,"start":211,"end":249}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P80370","model_url":"https://alphafold.ebi.ac.uk/files/AF-P80370-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P80370-F1-predicted_aligned_error_v6.png","plddt_mean":71.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DLK1","jax_strain_url":"https://www.jax.org/strain/search?query=DLK1"},"sequence":{"accession":"P80370","fasta_url":"https://rest.uniprot.org/uniprotkb/P80370.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P80370/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P80370"}},"corpus_meta":[{"pmid":"8500166","id":"PMC_8500166","title":"Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation.","date":"1993","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8500166","citation_count":578,"is_preprint":false},{"pmid":"12101250","id":"PMC_12101250","title":"Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12101250","citation_count":382,"is_preprint":false},{"pmid":"18471925","id":"PMC_18471925","title":"Genomic imprinting at the mammalian Dlk1-Dio3 domain.","date":"2008","source":"Trends in genetics : TIG","url":"https://pubmed.ncbi.nlm.nih.gov/18471925","citation_count":339,"is_preprint":false},{"pmid":"19737525","id":"PMC_19737525","title":"The DLK-1 kinase promotes mRNA stability and local translation in C. elegans synapses and axon regeneration.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19737525","citation_count":294,"is_preprint":false},{"pmid":"9819428","id":"PMC_9819428","title":"Delta-1 activation of notch-1 signaling results in HES-1 transactivation.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9819428","citation_count":283,"is_preprint":false},{"pmid":"12665558","id":"PMC_12665558","title":"Isolation of hepatoblasts based on the expression of Dlk/Pref-1.","date":"2003","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/12665558","citation_count":279,"is_preprint":false},{"pmid":"22825660","id":"PMC_22825660","title":"The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis.","date":"2012","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/22825660","citation_count":227,"is_preprint":false},{"pmid":"12588883","id":"PMC_12588883","title":"Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1).","date":"2003","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/12588883","citation_count":223,"is_preprint":false},{"pmid":"15068508","id":"PMC_15068508","title":"Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1.","date":"2004","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/15068508","citation_count":197,"is_preprint":false},{"pmid":"19541743","id":"PMC_19541743","title":"Minireview: Pref-1: role in adipogenesis and mesenchymal cell fate.","date":"2009","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/19541743","citation_count":188,"is_preprint":false},{"pmid":"19254573","id":"PMC_19254573","title":"Pref-1 regulates mesenchymal cell commitment and differentiation through Sox9.","date":"2009","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19254573","citation_count":185,"is_preprint":false},{"pmid":"9001251","id":"PMC_9001251","title":"Cleavage of membrane-associated pref-1 generates a soluble inhibitor of adipocyte differentiation.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9001251","citation_count":170,"is_preprint":false},{"pmid":"9202217","id":"PMC_9202217","title":"TNF alpha-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARgamma without effects on Pref-1 expression.","date":"1997","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9202217","citation_count":167,"is_preprint":false},{"pmid":"10605019","id":"PMC_10605019","title":"A role for pref-1 and HES-1 in thymocyte development.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10605019","citation_count":164,"is_preprint":false},{"pmid":"17116701","id":"PMC_17116701","title":"Pref-1, a preadipocyte secreted factor that inhibits adipogenesis.","date":"2006","source":"The Journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/17116701","citation_count":156,"is_preprint":false},{"pmid":"28324015","id":"PMC_28324015","title":"Paternally Inherited DLK1 Deletion Associated With Familial Central Precocious Puberty.","date":"2017","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/28324015","citation_count":147,"is_preprint":false},{"pmid":"22353464","id":"PMC_22353464","title":"Possible roles of DLK1 in the Notch pathway during development and disease.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22353464","citation_count":145,"is_preprint":false},{"pmid":"10997592","id":"PMC_10997592","title":"Does fetal antigen 1 (FA1) identify cells with regenerative, endocrine and neuroendocrine potentials? A study of FA1 in embryonic, fetal, and placental tissue and in maternal circulation.","date":"2000","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/10997592","citation_count":139,"is_preprint":false},{"pmid":"7925474","id":"PMC_7925474","title":"Protein structure of fetal antigen 1 (FA1). A novel circulating human epidermal-growth-factor-like protein expressed in neuroendocrine tumors and its relation to the gene products of dlk and pG2.","date":"1994","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7925474","citation_count":138,"is_preprint":false},{"pmid":"23840193","id":"PMC_23840193","title":"Pref-1, a gatekeeper of adipogenesis.","date":"2013","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/23840193","citation_count":136,"is_preprint":false},{"pmid":"31547048","id":"PMC_31547048","title":"Astragalus polysaccharides (PG2) Enhances the M1 Polarization of Macrophages, Functional Maturation of Dendritic Cells, and T Cell-Mediated Anticancer Immune Responses in Patients with Lung Cancer.","date":"2019","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/31547048","citation_count":136,"is_preprint":false},{"pmid":"17210639","id":"PMC_17210639","title":"Pref-1 (preadipocyte factor 1) activates the MEK/extracellular signal-regulated kinase pathway to inhibit adipocyte differentiation.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17210639","citation_count":135,"is_preprint":false},{"pmid":"10607588","id":"PMC_10607588","title":"Autonomous and non-autonomous regulation of mammalian neurite development by Notch1 and Delta1.","date":"1999","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/10607588","citation_count":132,"is_preprint":false},{"pmid":"10212243","id":"PMC_10212243","title":"Transcriptional repression of pref-1 by glucocorticoids promotes 3T3-L1 adipocyte differentiation.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10212243","citation_count":131,"is_preprint":false},{"pmid":"20457810","id":"PMC_20457810","title":"Pref-1 interacts with fibronectin to inhibit adipocyte differentiation.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20457810","citation_count":127,"is_preprint":false},{"pmid":"17320900","id":"PMC_17320900","title":"The EGF-like protein dlk1 inhibits notch signaling and potentiates adipogenesis of mesenchymal cells.","date":"2006","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17320900","citation_count":113,"is_preprint":false},{"pmid":"25088414","id":"PMC_25088414","title":"Pref-1 marks very early mesenchymal precursors required for adipose tissue development and expansion.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25088414","citation_count":107,"is_preprint":false},{"pmid":"7519443","id":"PMC_7519443","title":"Structural characterization and alternate splicing of the gene encoding the preadipocyte EGF-like protein pref-1.","date":"1994","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7519443","citation_count":104,"is_preprint":false},{"pmid":"15498495","id":"PMC_15498495","title":"Ectopic expression of DLK1 protein in skeletal muscle of padumnal heterozygotes causes the callipyge phenotype.","date":"2004","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/15498495","citation_count":104,"is_preprint":false},{"pmid":"9927597","id":"PMC_9927597","title":"Delta1 expression during avian hair cell regeneration.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9927597","citation_count":95,"is_preprint":false},{"pmid":"16456855","id":"PMC_16456855","title":"Dlk1 expression marks developing endothelium and sites of branching morphogenesis in the mouse embryo and placenta.","date":"2006","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/16456855","citation_count":95,"is_preprint":false},{"pmid":"18401542","id":"PMC_18401542","title":"Human Delta1-pyrroline-5-carboxylate synthase: function and regulation.","date":"2008","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/18401542","citation_count":88,"is_preprint":false},{"pmid":"18209061","id":"PMC_18209061","title":"Suppression of Th2 cell development by Notch ligands Delta1 and Delta4.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18209061","citation_count":87,"is_preprint":false},{"pmid":"30462238","id":"PMC_30462238","title":"DLK1 Is a Novel Link Between Reproduction and Metabolism.","date":"2019","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/30462238","citation_count":86,"is_preprint":false},{"pmid":"23141066","id":"PMC_23141066","title":"Regulation of DLK-1 kinase activity by calcium-mediated dissociation from an inhibitory isoform.","date":"2012","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/23141066","citation_count":84,"is_preprint":false},{"pmid":"15959531","id":"PMC_15959531","title":"Dlk1 in normal and abnormal hematopoiesis.","date":"2005","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/15959531","citation_count":80,"is_preprint":false},{"pmid":"16288219","id":"PMC_16288219","title":"DLK1: increased expression in gliomas and associated with oncogenic activities.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16288219","citation_count":72,"is_preprint":false},{"pmid":"11126233","id":"PMC_11126233","title":"Function of pref-1 as an inhibitor of adipocyte differentiation.","date":"2000","source":"International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity","url":"https://pubmed.ncbi.nlm.nih.gov/11126233","citation_count":71,"is_preprint":false},{"pmid":"15806146","id":"PMC_15806146","title":"Expression of DLK1 in hematopoietic cells results in inhibition of differentiation and proliferation.","date":"2005","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15806146","citation_count":71,"is_preprint":false},{"pmid":"22298767","id":"PMC_22298767","title":"Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22298767","citation_count":70,"is_preprint":false},{"pmid":"18513163","id":"PMC_18513163","title":"Dlk1 influences differentiation and function of B lymphocytes.","date":"2008","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/18513163","citation_count":68,"is_preprint":false},{"pmid":"15567716","id":"PMC_15567716","title":"Expression of Dlk/Pref-1 defines a subpopulation in the oval cell compartment of rat liver.","date":"2004","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/15567716","citation_count":68,"is_preprint":false},{"pmid":"10473134","id":"PMC_10473134","title":"Expression of the mouse Delta1 gene during organogenesis and fetal development.","date":"1999","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/10473134","citation_count":66,"is_preprint":false},{"pmid":"9822638","id":"PMC_9822638","title":"Transcriptional control of the pref-1 gene in 3T3-L1 adipocyte differentiation. Sequence requirement for differentiation-dependent suppression.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9822638","citation_count":64,"is_preprint":false},{"pmid":"11841846","id":"PMC_11841846","title":"Expression of Notch ligands, Jagged1, 2 and Delta1 in antigen presenting cells in mice.","date":"2002","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/11841846","citation_count":64,"is_preprint":false},{"pmid":"24621612","id":"PMC_24621612","title":"DLK1 promotes lung cancer cell invasion through upregulation of MMP9 expression depending on Notch signaling.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24621612","citation_count":63,"is_preprint":false},{"pmid":"25263792","id":"PMC_25263792","title":"ICR noncoding RNA expression controls imprinting and DNA replication at the Dlk1-Dio3 domain.","date":"2014","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/25263792","citation_count":62,"is_preprint":false},{"pmid":"17446189","id":"PMC_17446189","title":"Dlk1/FA1 is a novel endocrine regulator of bone and fat mass and its serum level is modulated by growth hormone.","date":"2007","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17446189","citation_count":60,"is_preprint":false},{"pmid":"7711066","id":"PMC_7711066","title":"dlk, pG2 and Pref-1 mRNAs encode similar proteins belonging to the EGF-like superfamily. Identification of polymorphic variants of this RNA.","date":"1995","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/7711066","citation_count":59,"is_preprint":false},{"pmid":"30930082","id":"PMC_30930082","title":"The imprinted gene Delta like non-canonical Notch ligand 1 (Dlk1) is conserved in mammals, and serves a growth modulatory role during tissue development and regeneration through Notch dependent and independent mechanisms.","date":"2019","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/30930082","citation_count":59,"is_preprint":false},{"pmid":"8985741","id":"PMC_8985741","title":"FA1 immunoreactivity in endocrine tumours and during development of the human fetal pancreas; negative correlation with glucagon expression.","date":"1996","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/8985741","citation_count":58,"is_preprint":false},{"pmid":"26728555","id":"PMC_26728555","title":"Regulation of the imprinted Dlk1-Dio3 locus by allele-specific enhancer activity.","date":"2016","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/26728555","citation_count":56,"is_preprint":false},{"pmid":"25349437","id":"PMC_25349437","title":"DLK1/PREF1 regulates nutrient metabolism and protects from steatosis.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25349437","citation_count":55,"is_preprint":false},{"pmid":"11742219","id":"PMC_11742219","title":"Neurons in the monoaminergic nuclei of the rat and human central nervous system express FA1/dlk.","date":"2001","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/11742219","citation_count":53,"is_preprint":false},{"pmid":"8882295","id":"PMC_8882295","title":"Mouse fetal antigen 1 (mFA1), the circulating gene product of mdlk, pref-1 and SCP-1: isolation, characterization and biology.","date":"1996","source":"Journal of reproduction and fertility","url":"https://pubmed.ncbi.nlm.nih.gov/8882295","citation_count":53,"is_preprint":false},{"pmid":"32023464","id":"PMC_32023464","title":"Heterogeneity of Satellite Cells Implicates DELTA1/NOTCH2 Signaling in Self-Renewal.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32023464","citation_count":52,"is_preprint":false},{"pmid":"21724852","id":"PMC_21724852","title":"Delta-like 1/fetal antigen-1 (Dlk1/FA1) is a novel regulator of chondrogenic cell differentiation via inhibition of the Akt kinase-dependent pathway.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21724852","citation_count":51,"is_preprint":false},{"pmid":"34627131","id":"PMC_34627131","title":"The role of delta-like non-canonical Notch ligand 1 (DLK1) in cancer.","date":"2021","source":"Endocrine-related cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34627131","citation_count":51,"is_preprint":false},{"pmid":"9607168","id":"PMC_9607168","title":"Molecular mechanisms of adipocyte differentiation and inhibitory action of pref-1.","date":"1997","source":"Critical reviews in eukaryotic gene expression","url":"https://pubmed.ncbi.nlm.nih.gov/9607168","citation_count":50,"is_preprint":false},{"pmid":"12651852","id":"PMC_12651852","title":"Insulin-like growth factor-1/insulin bypasses Pref-1/FA1-mediated inhibition of adipocyte differentiation.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12651852","citation_count":49,"is_preprint":false},{"pmid":"29784783","id":"PMC_29784783","title":"Postsynaptic δ1 glutamate receptor assembles and maintains hippocampal synapses via Cbln2 and neurexin.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29784783","citation_count":49,"is_preprint":false},{"pmid":"12660879","id":"PMC_12660879","title":"Pref-1 and ADSF/resistin: two secreted factors inhibiting adipose tissue development.","date":"2002","source":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme","url":"https://pubmed.ncbi.nlm.nih.gov/12660879","citation_count":48,"is_preprint":false},{"pmid":"30311912","id":"PMC_30311912","title":"Dlk1-Dio3 locus-derived lncRNAs perpetuate postmitotic motor neuron cell fate and subtype identity.","date":"2018","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30311912","citation_count":48,"is_preprint":false},{"pmid":"12191003","id":"PMC_12191003","title":"Expression of preadipocyte factor-1(Pref-1), a delta-like protein, in healing mouse ears.","date":"2002","source":"Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society","url":"https://pubmed.ncbi.nlm.nih.gov/12191003","citation_count":47,"is_preprint":false},{"pmid":"29383634","id":"PMC_29383634","title":"Soluble delta-like 1 homolog (DLK1) stimulates angiogenesis through Notch1/Akt/eNOS signaling in endothelial cells.","date":"2018","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/29383634","citation_count":47,"is_preprint":false},{"pmid":"22563444","id":"PMC_22563444","title":"DLK1 is a somato-dendritic protein expressed in hypothalamic arginine-vasopressin and oxytocin neurons.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22563444","citation_count":45,"is_preprint":false},{"pmid":"31972862","id":"PMC_31972862","title":"DLK1, Notch Signaling and the Timing of Puberty.","date":"2020","source":"Seminars in reproductive medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31972862","citation_count":44,"is_preprint":false},{"pmid":"17549051","id":"PMC_17549051","title":"Anti-adipogenic action of pitavastatin occurs through the coordinate regulation of PPARgamma and Pref-1 expression.","date":"2007","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17549051","citation_count":44,"is_preprint":false},{"pmid":"9831652","id":"PMC_9831652","title":"Expression patterns of Notch1, Serrate1, Serrate2 and Delta1 in tissues of the developing chick limb.","date":"1998","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9831652","citation_count":42,"is_preprint":false},{"pmid":"18392037","id":"PMC_18392037","title":"Human serum levels of fetal antigen 1 (FA1/Dlk1) increase with obesity, are negatively associated with insulin sensitivity and modulate inflammation in vitro.","date":"2008","source":"International journal of obesity (2005)","url":"https://pubmed.ncbi.nlm.nih.gov/18392037","citation_count":41,"is_preprint":false},{"pmid":"34606325","id":"PMC_34606325","title":"Emerging Roles of DLK1 in the Stem Cell Niche and Cancer Stemness.","date":"2021","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/34606325","citation_count":39,"is_preprint":false},{"pmid":"32526833","id":"PMC_32526833","title":"The Role of Pref-1 during Adipogenic Differentiation: An Overview of Suggested Mechanisms.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32526833","citation_count":38,"is_preprint":false},{"pmid":"8512086","id":"PMC_8512086","title":"Fetal antigen 1 (FA1) in the human pancreas: cell type expression, topological and quantitative variations during development.","date":"1993","source":"Anatomy and embryology","url":"https://pubmed.ncbi.nlm.nih.gov/8512086","citation_count":37,"is_preprint":false},{"pmid":"24810406","id":"PMC_24810406","title":"RPM-1 uses both ubiquitin ligase and phosphatase-based mechanisms to regulate DLK-1 during neuronal development.","date":"2014","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24810406","citation_count":37,"is_preprint":false},{"pmid":"30355480","id":"PMC_30355480","title":"Sox9-Meis1 Inactivation Is Required for Adipogenesis, Advancing Pref-1+ to PDGFRα+ Cells.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/30355480","citation_count":36,"is_preprint":false},{"pmid":"17485162","id":"PMC_17485162","title":"Regulation of growth hormone expression by Delta-like protein 1 (Dlk1).","date":"2007","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17485162","citation_count":36,"is_preprint":false},{"pmid":"31945419","id":"PMC_31945419","title":"Striatal glutamate delta-1 receptor regulates behavioral flexibility and thalamostriatal connectivity.","date":"2020","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/31945419","citation_count":33,"is_preprint":false},{"pmid":"8680480","id":"PMC_8680480","title":"Characterization of Pref-1 and its inhibitory role in adipocyte differentiation.","date":"1996","source":"International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity","url":"https://pubmed.ncbi.nlm.nih.gov/8680480","citation_count":29,"is_preprint":false},{"pmid":"22324440","id":"PMC_22324440","title":"Pref-1 in brown adipose tissue: specific involvement in brown adipocyte differentiation and regulatory role of C/EBPδ.","date":"2012","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/22324440","citation_count":29,"is_preprint":false},{"pmid":"33712542","id":"PMC_33712542","title":"Dlk1 dosage regulates hippocampal neurogenesis and cognition.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33712542","citation_count":28,"is_preprint":false},{"pmid":"25359212","id":"PMC_25359212","title":"RHGF-1/PDZ-RhoGEF and retrograde DLK-1 signaling drive neuronal remodeling on microtubule disassembly.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25359212","citation_count":28,"is_preprint":false},{"pmid":"22142700","id":"PMC_22142700","title":"DLK1, delta-like 1 homolog (Drosophila), regulates tumor cell differentiation in vivo.","date":"2011","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/22142700","citation_count":28,"is_preprint":false},{"pmid":"35544282","id":"PMC_35544282","title":"Epigenome editing reveals core DNA methylation for imprinting control in the Dlk1-Dio3 imprinted domain.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/35544282","citation_count":28,"is_preprint":false},{"pmid":"29996488","id":"PMC_29996488","title":"A Hearty Dose of Noncoding RNAs: The Imprinted DLK1-DIO3 Locus in Cardiac Development and Disease.","date":"2018","source":"Journal of cardiovascular development and disease","url":"https://pubmed.ncbi.nlm.nih.gov/29996488","citation_count":26,"is_preprint":false},{"pmid":"9888532","id":"PMC_9888532","title":"Implication of ZOG protein (zona glomerulosa-specific protein) in zone development of the adrenal cortex.","date":"1998","source":"Endocrine research","url":"https://pubmed.ncbi.nlm.nih.gov/9888532","citation_count":24,"is_preprint":false},{"pmid":"32924531","id":"PMC_32924531","title":"Astragalus Polysaccharide (PG2) Suppresses Macrophage Migration Inhibitory Factor and Aggressiveness of Lung Adenocarcinoma Cells.","date":"2020","source":"The American journal of Chinese medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32924531","citation_count":24,"is_preprint":false},{"pmid":"19084046","id":"PMC_19084046","title":"Pref-1 and adipokine expression in adipose tissues of GK and Zucker rats.","date":"2008","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19084046","citation_count":24,"is_preprint":false},{"pmid":"28715922","id":"PMC_28715922","title":"DLK1-DIO3 imprinted locus deregulation in development, respiratory disease, and cancer.","date":"2017","source":"Expert review of respiratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28715922","citation_count":24,"is_preprint":false},{"pmid":"19427405","id":"PMC_19427405","title":"Expression regulation and function of Pref-1 during adipogenesis of human mesenchymal stem cells (MSCs).","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19427405","citation_count":23,"is_preprint":false},{"pmid":"20058200","id":"PMC_20058200","title":"Isolation and differentiation of chondrocytic cells derived from human embryonic stem cells using dlk1/FA1 as a novel surface marker.","date":"2009","source":"Stem cell reviews and reports","url":"https://pubmed.ncbi.nlm.nih.gov/20058200","citation_count":22,"is_preprint":false},{"pmid":"18575777","id":"PMC_18575777","title":"Expression of Dlk1 gene in myelodysplastic syndrome determined by microarray, and its effects on leukemia cells.","date":"2008","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18575777","citation_count":22,"is_preprint":false},{"pmid":"39454577","id":"PMC_39454577","title":"A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma.","date":"2024","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/39454577","citation_count":21,"is_preprint":false},{"pmid":"17451526","id":"PMC_17451526","title":"Expression of ksdD gene encoding 3-ketosteroid-Delta1-dehydrogenase from Arthrobacter simplex in Bacillus subtilis.","date":"2007","source":"Letters in applied microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/17451526","citation_count":21,"is_preprint":false},{"pmid":"24582655","id":"PMC_24582655","title":"Membrane-bound delta-like 1 homolog (Dlk1) promotes while soluble Dlk1 inhibits myogenesis in C2C12 cells.","date":"2014","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/24582655","citation_count":20,"is_preprint":false},{"pmid":"10543989","id":"PMC_10543989","title":"Genomic organization and genetic mapping of the bovine PREF-1 gene.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10543989","citation_count":19,"is_preprint":false},{"pmid":"21637593","id":"PMC_21637593","title":"Expression of DLK1 and MEG3 genes in porcine tissues during postnatal development.","date":"2010","source":"Genetics and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21637593","citation_count":18,"is_preprint":false},{"pmid":"17471553","id":"PMC_17471553","title":"Expansion and characterization of ventral mesencephalic precursor cells: effect of mitogens and investigation of FA1 as a potential dopaminergic marker.","date":"2007","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/17471553","citation_count":18,"is_preprint":false},{"pmid":"30315226","id":"PMC_30315226","title":"Glutamate delta-1 receptor regulates cocaine-induced plasticity in the nucleus accumbens.","date":"2018","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/30315226","citation_count":18,"is_preprint":false},{"pmid":"18344616","id":"PMC_18344616","title":"Synergistic role of Igf2 and Dlk1 in fetal liver development and hematopoiesis in bi-maternal mice.","date":"2008","source":"The Journal of reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/18344616","citation_count":18,"is_preprint":false},{"pmid":"26803505","id":"PMC_26803505","title":"A xylanase from Streptomyces sp. FA1: heterologous expression, characterization, and its application in Chinese steamed bread.","date":"2016","source":"Journal of industrial microbiology & biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/26803505","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49501,"output_tokens":8442,"usd":0.137567,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18186,"output_tokens":5564,"usd":0.115015,"stage2_stop_reason":"end_turn"},"total_usd":0.252582,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"Pref-1 (DLK1) is synthesized as a transmembrane protein with six tandem EGF-like repeats; constitutive expression in 3T3-L1 preadipocytes blocks down-regulation of Pref-1 and drastically inhibits adipocyte differentiation, establishing it as a negative regulator of adipogenesis.\",\n      \"method\": \"cDNA cloning, constitutive expression/overexpression in 3T3-L1 preadipocytes with differentiation assay\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function via constitutive expression with clear cellular phenotype; foundational paper replicated extensively across labs\",\n      \"pmids\": [\"8500166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The pref-1 gene consists of five exons and four introns spanning ~7.3 kb; at least five alternatively spliced forms are produced with in-frame deletions affecting the sixth EGF-like repeat, juxtamembrane, and transmembrane domains, establishing that alternate splicing generates structural diversity in DLK1 isoforms.\",\n      \"method\": \"Genomic cloning, RT-PCR, primer extension, transient transfection reporter assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct genomic and cDNA characterization with functional promoter validation; replicated by subsequent studies\",\n      \"pmids\": [\"7519443\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"FA1 (the circulating soluble form of DLK1) is a single-chain glycoprotein with six EGF-like repeats containing up to ten O- and N-glycosylation sites; it is 99% identical to the protein encoded by human dlk/pG2 and co-localizes with insulin in beta-cell secretory granules of the pancreas.\",\n      \"method\": \"Protein purification from amniotic fluid, amino acid sequencing, glycosylation mapping, immunohistochemistry\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct protein sequencing and structural characterization with immunohistochemical validation\",\n      \"pmids\": [\"7925474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Membrane-associated Pref-1 is proteolytically cleaved in the juxtamembrane region to generate a ~50 kDa soluble ectodomain and smaller 24–31 kDa products; only the two largest alternatively spliced isoforms (which retain the processing site) undergo cleavage. The purified soluble ectodomain alone is sufficient to block 3T3-L1 adipocyte differentiation, demonstrating a paracrine inhibitory mechanism.\",\n      \"method\": \"Cell-free cleavage assay, immunoprecipitation of conditioned medium, E. coli expression of ectodomain, adipogenesis inhibition assay with antibody blocking\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with purified protein plus antibody neutralization; replicated in multiple subsequent studies\",\n      \"pmids\": [\"9001251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Transcription of the pref-1 gene is repressed by dexamethasone (glucocorticoids) as an early event during adipogenic induction; a specific -183 to -170 bp 'SAD' (suppression in adipocyte differentiation) element mediates this differentiation-dependent suppression, and an ~63 kDa nuclear protein binds this element.\",\n      \"method\": \"Nuclear run-on transcription assay, actinomycin D half-life measurement, stable transfection of 5'-deletion reporter constructs, gel mobility shift assay, UV cross-linking\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (run-on, deletion mapping, gel shift) in a single rigorous study\",\n      \"pmids\": [\"9822638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Glucocorticoid (dexamethasone)-mediated repression of pref-1 transcription contributes to promotion of adipogenesis; antisense pref-1 expression lowers endogenous pref-1 and enhances adipose conversion at sub-threshold dexamethasone concentrations, demonstrating that pref-1 down-regulation is required for adipoconversion.\",\n      \"method\": \"Stable antisense transfection in 3T3-L1, dose-response differentiation assay, nuclear run-on, actinomycin D chase\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — antisense knockdown with functional rescue and mechanistic controls; replicated across labs\",\n      \"pmids\": [\"10212243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Pref-1/Dlk1 knockout mice display growth retardation, obesity, blepharophimosis, skeletal malformation, and increased serum lipids; the phenotype is present only in heterozygotes with a paternally inherited null allele, confirming that Pref-1 is a paternally expressed imprinted gene required for normal development and adipose tissue homeostasis.\",\n      \"method\": \"Gene-targeted knockout mouse generation, heterozygous parental cross analysis, body composition measurement, lipid metabolite assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined phenotype and parent-of-origin genetics; foundational in vivo loss-of-function study\",\n      \"pmids\": [\"12101250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Transgenic mice expressing the large soluble Pref-1 ectodomain (fused to human IgG Fc) in adipose tissue show substantial reduction in fat pad weight and decreased adipocyte marker expression; liver-specific expression also reduces adipose mass, demonstrating an endocrine (circulating) mode of action for soluble Pref-1 in inhibiting adipogenesis in vivo.\",\n      \"method\": \"Transgenic mouse generation with aP2 and albumin promoter-driven Pref-1/hFc, fat pad weighing, adipocyte gene expression, serum metabolite analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo gain-of-function with two promoter-driven transgenic lines demonstrating endocrine mechanism\",\n      \"pmids\": [\"12588883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Overexpression of DLK1/Pref-1 in human marrow stromal (mesenchymal stem) cells inhibits both adipocyte and osteoblast differentiation without affecting proliferation, maintaining cells in a bipotential undifferentiated state; late-stage differentiation markers are suppressed while lineage commitment markers are unaffected.\",\n      \"method\": \"Retroviral stable transduction of hMSC-TERT, cytochemical staining, FACS, real-time PCR, ex vivo calvaria organ culture bone formation assay\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KD/OE with multiple differentiation readouts, single lab\",\n      \"pmids\": [\"15068508\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Ectopic DLK1 protein expression in skeletal muscle of callipyge sheep (padumnal heterozygotes, +(MAT)/CLPG(PAT)) is perfectly correlated with muscular hypertrophy; transgenic mice expressing DLK1 in skeletal muscle develop generalized muscular hypertrophy, establishing DLK1 protein as the causal agent of the callipyge phenotype.\",\n      \"method\": \"Immunohistochemistry of sheep skeletal muscle, transgenic mouse generation with skeletal muscle-specific DLK1 expression, muscle mass quantification\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — correlative data in sheep plus causal transgenic mouse model with defined phenotype\",\n      \"pmids\": [\"15498495\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"DLK1 expression in hematopoietic HL-60 cells inhibits differentiation and proliferation; this inhibitory effect requires the intracellular domain of DLK1, not proteolytic release of the extracellular domain, identifying a novel intracellular domain-dependent mechanism distinct from the soluble ectodomain mechanism operative in preadipocytes.\",\n      \"method\": \"Stable transfection of HL-60 cells with full-length and domain-deletion DLK1 constructs, differentiation assay, proliferation assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain deletion analysis with cellular functional readout, single lab\",\n      \"pmids\": [\"15806146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DLK1 potentiates adipogenesis in mesenchymal C3H10T1/2 cells (in contrast to its inhibitory effect in preadipocytes); this potentiating effect requires the extracellular EGF-like domain and Notch1 expression, and is associated with altered ERK1/2 activation, demonstrating context-dependent and Notch1-dependent DLK1 action.\",\n      \"method\": \"Overexpression of full-length DLK1, EGF domain only, and intracellular domain constructs in C3H10T1/2; coculture assay; Notch1 siRNA knockdown; ERK1/2 phosphorylation western blot; adipogenesis quantification\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple domain constructs and siRNA knockdown with functional readout, single lab\",\n      \"pmids\": [\"17320900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Soluble Pref-1 activates the MEK/ERK pathway in a time- and dose-dependent manner; ERK phosphorylation by Pref-1 is required for inhibition of adipogenesis, as MEK inhibitor PD98059 or ERK1/2 siRNA knockdown abolishes Pref-1's inhibitory effect on adipocyte differentiation (primarily by preventing PPARγ2 induction).\",\n      \"method\": \"Purified soluble Pref-1 treatment of Pref-1-null MEF, phospho-ERK western blot, MEK inhibitor (PD98059) treatment, ERK1/2 siRNA knockdown, lipid accumulation and adipocyte marker expression assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with purified protein in null cells plus pharmacological and genetic inhibition of pathway; multiple orthogonal methods\",\n      \"pmids\": [\"17210639\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Circulating FA1 (soluble DLK1) reduces total body weight, fat mass, and bone mass in mice in a dose-dependent manner when overexpressed via hydrodynamic gene transfer; serum FA1 levels are regulated by growth hormone (GH increases FA1 clearance; hypophysectomy increases FA1 ~450%; GH treatment reduces it ~40%), identifying GH as a modulator of circulating DLK1.\",\n      \"method\": \"Hydrodynamic gene transfer in mice, ELISA for FA1, DEXA body composition, bone histomorphometry, GH manipulation (hydrodynamic GH transfer, hypophysectomy)\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo gain-of-function with dose-response and hormonal manipulation, single lab\",\n      \"pmids\": [\"17446189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"DLK1 represses growth hormone (GH) promoter activity in pituitary GH3 cells; this repression requires Pit-1 binding sites in the GH promoter and is independent of DLK1's EGF-like repeats and MAP kinase-modulating activity, identifying GH as a DLK1-regulated target gene via a Pit-1-dependent transcriptional mechanism.\",\n      \"method\": \"Stable DLK1 expression in GH3 cells, GH mRNA/protein/secretion assay, GH promoter-luciferase reporter cotransfection, deletion/mutation analysis of promoter, Pit-1 cotransfection, domain deletion analysis of DLK1\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter deletion/mutation mapping with functional reporter and domain analysis, single lab\",\n      \"pmids\": [\"17485162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Pref-1 inhibits adipocyte differentiation by upregulating Sox9 expression; Sox9 directly binds the C/EBPβ and C/EBPδ promoters to suppress their activity. Sox9 downregulation is required for adipocyte differentiation to proceed. Furthermore, by inducing Sox9, Pref-1 promotes chondrogenic induction but prevents chondrocyte maturation and osteoblast differentiation.\",\n      \"method\": \"Sox9 siRNA knockdown, Sox9 overexpression, chromatin immunoprecipitation (ChIP) of Sox9 on C/EBP promoters, Pref-1 null and transgenic mice in vivo validation, adipocyte/chondrocyte/osteoblast differentiation assays\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — ChIP identifies direct Sox9 binding, siRNA knockdown, overexpression, and in vivo validation across multiple lineages in one study\",\n      \"pmids\": [\"19254573\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Pref-1 is cleaved by TACE (ADAM17/TNF-α-converting enzyme) to generate the biologically active 50 kDa soluble form; only this large soluble form (not the small soluble or transmembrane forms) is biologically active to inhibit adipogenesis.\",\n      \"method\": \"TACE inhibitor treatment, isoform-specific overexpression, adipogenesis assay\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological TACE inhibition and isoform comparison, single lab review citing prior experimental work\",\n      \"pmids\": [\"19541743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Pref-1 directly interacts with fibronectin via its juxtamembrane domain; this interaction requires fibronectin binding to α5-integrin. Fibronectin is required for Pref-1-mediated ERK/MAPK activation, Sox9 upregulation, and inhibition of adipocyte differentiation. Pref-1 activates integrin downstream signaling molecules FAK and Rac, and ERK activation by Pref-1 is blocked by Rac knockdown or dominant-negative Rac. Pref-1 does not interact with or require Notch for its adipogenic inhibitory function.\",\n      \"method\": \"Co-immunoprecipitation of Pref-1 and fibronectin, fibronectin siRNA knockdown, RGD peptide competition, α5-integrin siRNA knockdown, dominant-negative Rac expression, FAK/Rac phosphorylation western blot, adipogenesis assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct protein interaction (Co-IP), multiple knockdowns, dominant-negative, and pathway readouts in a single rigorous study; also contains explicit negative result ruling out Notch\",\n      \"pmids\": [\"20457810\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DLK1/FA1 inhibits chondrogenic differentiation of ATDC5 cells in a dose-dependent manner at all stages (proliferation, differentiation, maturation, hypertrophic conversion); this inhibition is mediated through suppression of the PI3K/Akt pathway (not ERK1/2 or p38 MAPK), and fibronectin siRNA rescue of Akt inhibition implicates fibronectin as a mediator of DLK1/FA1-Akt signaling in chondrogenic cells.\",\n      \"method\": \"Stable overexpression and conditioned medium treatment in ATDC5 cells, purified FA1 protein addition, Akt/ERK/p38 western blot, fibronectin siRNA knockdown, cartilage nodule formation assay, collagen type II/X and aggrecan gene expression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — purified protein plus multiple pathway inhibition readouts and siRNA, single lab\",\n      \"pmids\": [\"21724852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DLK1 is expressed selectively in hepatic stellate cells (HSCs) in adult liver; DLK1 knockdown in activated HSCs causes suppression of necdin and Wnt, epigenetic derepression of PPARγ, and morphologic/functional reversal to quiescent cells. Anti-DLK1 antibody administration after partial hepatectomy reduces early hepatocyte proliferation and liver growth, with decreased Wnt10b, β-catenin, cyclins, CDKs, p-ERK1/2, and p-AKT.\",\n      \"method\": \"DLK1 siRNA knockdown in HSCs, anti-DLK1 antibody tail vein injection post-partial hepatectomy, HSC/hepatocyte co-culture, western blot for Wnt/β-catenin/cyclin/CDK/ERK/AKT pathway components\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro knockdown and in vivo antibody neutralization with pathway readouts, single lab\",\n      \"pmids\": [\"22298767\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"C/EBPδ activates Pref-1 gene transcription in brown adipocytes through binding to the proximal Pref-1 promoter region; C/EBPδ siRNA knockdown reduces Pref-1 expression, and Pref-1 controls the thermogenic gene expression program (UCP1, PGC-1α) in brown adipose tissue.\",\n      \"method\": \"C/EBPδ siRNA knockdown, promoter-reporter assay, ChIP for C/EBPδ binding, Pref-1 mRNA measurement, Pref-1-null mouse brown adipose tissue analysis\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown, reporter assay, and null mouse validation, single lab\",\n      \"pmids\": [\"22324440\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Pref-1-marked cells are very early mesenchymal adipose precursors, prior to Zfp423 or PPARγ expression, and Pref-1+ cells are of mesenchymal (not endothelial or pericytal) origin. Ablation of Pref-1-marked cells prevents both embryonic white adipose tissue development and adult adipose expansion upon high-fat feeding, demonstrating that Pref-1+ cells are required for adipogenesis.\",\n      \"method\": \"Pref-1 promoter-rtTA transgenic mice with inducible fluorescent labeling and diphtheria toxin-mediated cell ablation, lineage tracing, embryonic and adult adipose tissue analysis, high-fat diet challenge\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic lineage tracing and inducible cell ablation with clear in vivo phenotype, multiple experimental approaches\",\n      \"pmids\": [\"25088414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DLK1 overexpression in lung cancer cells promotes invasion through upregulation of MMP9 expression; this MMP9 upregulation depends on Notch signaling, as it is blocked by γ-secretase inhibitor (GSI) treatment, and DLK1 activates Notch signaling (NOTCH1/HES1/NICD nuclear translocation) in lung cancer cells.\",\n      \"method\": \"DLK1 overexpression and knockdown in lung cancer cell lines, transwell invasion assay, western blot and gelatin zymography for MMP9, NOTCH1/HES1 expression and NICD nuclear translocation assay, GSI treatment\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — overexpression, knockdown, and pharmacological inhibition with multiple functional readouts, single lab\",\n      \"pmids\": [\"24621612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DLK1 overexpression causes improved glucose tolerance, reduced fat stores, pituitary IGF1 resistance, defective GH feedback regulation, increased circulatory GH, and a switch in whole-body fuel metabolism toward peripheral lipid oxidation and reduced hepatic steatosis, identifying DLK1's physiological function as shifting metabolic mode away from lipid storage.\",\n      \"method\": \"Knock-in mouse overexpressing Dlk1 from endogenous control elements, glucose tolerance test, body composition, hepatic lipid measurement, GH/IGF1 axis analysis, metabolic cage studies\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — endogenous knock-in model with comprehensive metabolic phenotyping across multiple axes\",\n      \"pmids\": [\"25349437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A paternally inherited genomic deletion of DLK1 (including the 5' UTR, first exon, and translational start site) causes familial central precocious puberty (CPP) with undetectable serum DLK1 levels; DLK1 is expressed in mouse hypothalamus and kisspeptin neuron-derived cell lines, implicating DLK1 as a regulator of pubertal timing through the hypothalamic-pituitary-gonadal axis.\",\n      \"method\": \"Linkage analysis, whole-genome sequencing, segregation analysis, ELISA for serum DLK1, in situ hybridization and qRT-PCR in mouse hypothalamus and kisspeptin cell lines\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — human loss-of-function genetics with serum protein measurement and hypothalamic expression validation, single study\",\n      \"pmids\": [\"28324015\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Soluble DLK1 (extracellular domain) stimulates angiogenesis by activating Notch1/Akt/eNOS/Hes-1 signaling in endothelial cells; pharmacological Notch blockade (DAPT) or Notch1 knockdown/antibody neutralization reverses DLK1-induced endothelial migration and HES-1 activation.\",\n      \"method\": \"Recombinant DLK1 extracellular domain protein treatment of endothelial cells, aortic ring sprouting assay, corneal neovascularization assay, luciferase Hes-1 reporter, DAPT treatment, Notch1 siRNA and neutralizing antibody, Akt/eNOS western blot\",\n      \"journal\": \"Angiogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — recombinant protein plus pharmacological and genetic Notch inhibition with in vitro and in vivo angiogenesis assays, single lab\",\n      \"pmids\": [\"29383634\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Sox9 inactivation in Pref-1+ early adipose precursors is required for their transition to PDGFRα+ cells that express early adipogenic markers; Sox9 maintains Pref-1+ cells in a proliferative precursor state by activating Meis1, which prevents adipogenic differentiation. Pref-1+ cells precede PDGFRα+ cells in the adipogenic pathway.\",\n      \"method\": \"Pref-1 promoter-rtTA inducible Sox9 knockout mice, fluorescent labeling and cell sorting, adipogenic marker gene expression, Meis1 overexpression and knockdown\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — inducible in vivo genetic epistasis (Pref-1-Sox9-Meis1 axis) with lineage tracing and multiple cellular readouts\",\n      \"pmids\": [\"30355480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Loss-of-function frameshift mutations of DLK1 (p.Gly199Alafs*11, p.Val271Cysfs*14, p.Pro160Leufs*50) cause familial central precocious puberty with undetectable serum DLK1; affected women show high prevalence of metabolic abnormalities (obesity, glucose intolerance, hyperlipidemia, polycystic ovary syndrome), demonstrating DLK1 as a link between reproduction and metabolism.\",\n      \"method\": \"DNA sequencing, segregation analysis, serum DLK1 ELISA, metabolic profiling of mutation carriers vs. controls\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — human loss-of-function genetics with serum protein assay and metabolic phenotyping, replication across three families\",\n      \"pmids\": [\"30462238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Short hairpin RNA-mediated silencing of DLK1 in neuroblastoma cells increases cellular differentiation; high DLK1 expression correlates with a super-enhancer and robust cell surface protein expression, and DLK1-targeting antibody-drug conjugate (ADCT-701) shows potent cytotoxicity in DLK1-expressing neuroblastoma xenograft models.\",\n      \"method\": \"shRNA DLK1 knockdown in neuroblastoma cells, differentiation assay, immunofluorescence/flow cytometry/IHC for cell surface DLK1, in vivo xenograft ADC treatment\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — shRNA loss-of-function with differentiation readout and in vivo ADC efficacy, single study\",\n      \"pmids\": [\"39454577\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Membrane-bound Dlk1 promotes myogenic differentiation (hypertrophic phenotype, higher fusion rate) in C2C12 cells, whereas soluble Dlk1 inhibits myotube formation, demonstrating that the two isoforms have opposing effects on myogenesis.\",\n      \"method\": \"Stable expression of membrane-bound vs. soluble Dlk1 isoforms in C2C12 cells, myotube formation assay, fusion rate quantification, myogenic gene expression\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific overexpression with functional differentiation readouts, single lab\",\n      \"pmids\": [\"24582655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In the subgranular zone (SGZ) of the hippocampus, Dlk1 is expressed biallelically (loss of canonical imprinting); both parental alleles are required for normal adult hippocampal neurogenesis and stem cell behavior. Reduction in Dlk1 dosage (maternal, paternal, or biallelic mutations) triggers specific cognitive abnormalities affecting discrimination of environmental stimuli.\",\n      \"method\": \"Dlk1 mutant mouse allele-specific expression analysis in SGZ, adult neurogenesis quantification, behavioral battery (spatial learning, anxiety, discrimination tasks)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — allele-specific expression analysis and loss-of-function mouse models with cellular and behavioral phenotypes, single study\",\n      \"pmids\": [\"33712542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In the hypothalamus, DLK1 is expressed predominantly as a soluble cleaved form; DLK1 protein is localized to somata and dendrites of arginine-vasopressin neurons in PVN, SCN, and SON and of oxytocin neurons in PVN and SON, suggesting a role in post-natal development of these neuroendocrine systems.\",\n      \"method\": \"Western blot of hypothalamus protein extracts, immunohistochemistry with co-labeling for AVP and oxytocin neuronal markers\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct protein localization by fractionation and immunohistochemistry, replicated co-labeling; no functional consequence directly tested\",\n      \"pmids\": [\"22563444\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DLK1 (Pref-1/FA1) is a paternally imprinted, transmembrane EGF-repeat protein that is proteolytically cleaved by TACE/ADAM17 to generate a biologically active ~50 kDa soluble ectodomain; the soluble form acts as an autocrine/paracrine inhibitor of adipogenesis by binding fibronectin, activating integrin→FAK/Rac→MEK/ERK signaling, and upregulating the transcription factor Sox9, which in turn suppresses C/EBPβ/δ expression; Sox9 also mediates DLK1's broader inhibition of osteoblast and chondrocyte differentiation, and DLK1 maintains early Pref-1+ mesenchymal precursors in an undifferentiated state that is required for adipose tissue development; membrane-bound DLK1 can additionally signal via its intracellular domain (in hematopoietic cells) or activate Notch1 signaling (in endothelial and lung cancer cells) in context-dependent manners, and loss-of-function mutations in humans cause familial central precocious puberty with metabolic abnormalities, while ectopic DLK1 expression in skeletal muscle drives hypertrophy.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DLK1 (Pref-1/FA1) is a paternally imprinted transmembrane protein bearing six tandem EGF-like repeats that functions as a master negative regulator of mesenchymal precursor differentiation, governing adipose, skeletal, and broader developmental programs [#0, #6]. The membrane-anchored protein is cleaved by TACE/ADAM17 in its juxtamembrane region to release a biologically active ~50 kDa soluble ectodomain, and only the larger alternatively spliced isoforms that retain the cleavage site are processed and active [#3, #16, #1]. This soluble form acts in a paracrine and endocrine manner to block adipogenesis in vivo [#7]. Mechanistically, soluble Pref-1 binds fibronectin through its juxtamembrane domain in an α5-integrin-dependent fashion, activating FAK/Rac and the downstream MEK/ERK cascade required to inhibit adipocyte differentiation, independently of Notch [#17, #12]. This signaling upregulates the transcription factor Sox9, which directly binds and represses the C/EBPβ and C/EBPδ promoters, and Sox9 likewise mediates DLK1's inhibition of chondrocyte maturation and osteoblast differentiation [#15]. DLK1 marks very early mesenchymal adipose precursors whose Sox9-dependent maintenance (via Meis1) holds them in an undifferentiated proliferative state required for both embryonic and adult adipose development [#21, #26]. Beyond fat, DLK1 reprograms systemic metabolism toward peripheral lipid oxidation and intersects the GH/IGF1 axis, repressing GH transcription via Pit-1 sites [#23, #14]. DLK1 also signals in context-dependent modes distinct from the canonical adipogenic pathway: its intracellular domain mediates inhibition of hematopoietic differentiation [#10], and it can activate Notch1 signaling to drive endothelial angiogenesis and lung cancer cell invasion [#25, #22]. Paternally inherited loss-of-function deletions and frameshift mutations in humans cause familial central precocious puberty accompanied by metabolic abnormalities [#24, #27].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Established DLK1's foundational identity and function: an unknown EGF-repeat transmembrane protein whose constitutive expression revealed it as a brake on adipocyte differentiation that must be downregulated for fat conversion.\",\n      \"evidence\": \"cDNA cloning and constitutive overexpression in 3T3-L1 preadipocytes with differentiation assays\",\n      \"pmids\": [\"8500166\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of inhibition undefined\", \"Soluble vs membrane-bound activity not yet distinguished\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Defined the structural diversity and circulating nature of DLK1, showing alternative splicing generates isoforms differing in the juxtamembrane/transmembrane region and that a soluble glycosylated form (FA1) circulates and co-localizes with insulin in beta-cell granules.\",\n      \"evidence\": \"Genomic cloning, RT-PCR, promoter reporter assays, and protein purification/sequencing from amniotic fluid with immunohistochemistry\",\n      \"pmids\": [\"7519443\", \"7925474\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional difference between isoforms not yet tested\", \"Significance of beta-cell localization unresolved\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Resolved how membrane DLK1 becomes the active species: juxtamembrane proteolytic cleavage releases a ~50 kDa ectodomain sufficient on its own to block adipogenesis, defining a paracrine mechanism and explaining why only the longest splice isoforms are active.\",\n      \"evidence\": \"Cell-free cleavage assays, conditioned-medium immunoprecipitation, recombinant ectodomain expression, and antibody-blocking adipogenesis assays\",\n      \"pmids\": [\"9001251\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the cleaving protease not yet established\", \"Receptor/binding partner for the ectodomain unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Connected hormonal control of adipogenesis to DLK1 by showing glucocorticoid-driven transcriptional repression of pref-1 (via a defined SAD promoter element) is required for adipoconversion.\",\n      \"evidence\": \"Nuclear run-on, promoter deletion reporters, gel shift/UV cross-linking, and antisense knockdown with dose-response differentiation in 3T3-L1\",\n      \"pmids\": [\"9822638\", \"10212243\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the ~63 kDa SAD-binding factor undefined\", \"Link between transcriptional control and protein-level signaling unmapped\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrated DLK1 acts in vivo, both as a paracrine and endocrine factor: paternally inherited null mice show obesity and developmental defects, while transgenic soluble ectodomain delivered from fat or liver reduces adipose mass systemically.\",\n      \"evidence\": \"Imprinted knockout mice with parent-of-origin crosses and aP2/albumin promoter-driven Pref-1/hFc transgenic lines with body composition analysis\",\n      \"pmids\": [\"12101250\", \"12588883\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling pathway in vivo not defined\", \"Tissue targets of circulating ectodomain unidentified\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Revealed that DLK1 signaling is context- and isoform-dependent, with the intracellular domain (not the released ectodomain) mediating inhibition of hematopoietic differentiation, expanding beyond the soluble paracrine paradigm.\",\n      \"evidence\": \"Domain-deletion DLK1 constructs in HL-60 cells with differentiation and proliferation assays\",\n      \"pmids\": [\"15806146\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Intracellular domain effectors unidentified\", \"Single cell-line context\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identified MEK/ERK as the signaling node through which soluble Pref-1 blocks adipogenesis, establishing a causal kinase pathway between the ectodomain and suppression of PPARγ2.\",\n      \"evidence\": \"Purified soluble Pref-1 on null MEFs with phospho-ERK blots, MEK inhibitor, and ERK1/2 siRNA\",\n      \"pmids\": [\"17210639\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream receptor linking ectodomain to MEK/ERK not yet identified\", \"How ERK suppresses PPARγ2 not detailed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined the transcriptional output and the activating protease: Pref-1-induced Sox9 directly represses C/EBPβ/δ to block adipogenesis (and broadly inhibit osteo/chondro maturation), while TACE/ADAM17 was identified as the sheddase generating the active 50 kDa form.\",\n      \"evidence\": \"Sox9 siRNA/overexpression, ChIP on C/EBP promoters, in vivo null/transgenic validation, and TACE inhibitor with isoform comparison\",\n      \"pmids\": [\"19254573\", \"19541743\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism coupling ERK to Sox9 induction unresolved\", \"TACE finding from review-cited pharmacology only\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified fibronectin/α5-integrin as the receptor system for soluble Pref-1, placing FAK/Rac upstream of ERK and explicitly excluding Notch from the adipogenic-inhibitory pathway.\",\n      \"evidence\": \"Co-IP of Pref-1 with fibronectin, fibronectin and α5-integrin siRNA, RGD competition, dominant-negative Rac, and FAK/Rac phospho-blots\",\n      \"pmids\": [\"20457810\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether a direct signaling receptor beyond integrin exists unknown\", \"Structural basis of juxtamembrane-fibronectin binding undefined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Extended DLK1 signaling to chondrogenesis through a distinct effector arm, showing FA1 suppresses chondrogenic differentiation via PI3K/Akt (not ERK/p38), with fibronectin again as a mediator.\",\n      \"evidence\": \"Overexpression/conditioned medium/purified FA1 in ATDC5 cells with Akt/ERK/p38 blots and fibronectin siRNA rescue\",\n      \"pmids\": [\"21724852\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cell-type basis for ERK- vs Akt-pathway choice unexplained\", \"Single lab/cell line\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Connected DLK1 to multiple organ systems and upstream regulation: C/EBPδ activates pref-1 in brown fat to control thermogenesis, DLK1 marks hepatic stellate cells and supports liver regeneration via Wnt, and hypothalamic DLK1 localizes to AVP/oxytocin neurons.\",\n      \"evidence\": \"C/EBPδ siRNA/ChIP and null-mouse brown fat analysis; HSC siRNA and anti-DLK1 antibody post-hepatectomy; hypothalamic fractionation and immunohistochemistry\",\n      \"pmids\": [\"22324440\", \"22298767\", \"22563444\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signaling mechanism in each tissue incompletely defined\", \"Functional role of neuronal DLK1 not directly tested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established DLK1 as a regulator of multiple precursor lineages and systemic metabolism: it marks the earliest mesenchymal adipose precursors required for fat development, opposingly regulates myogenesis by isoform, drives muscular hypertrophy (callipyge), activates Notch in lung cancer invasion, and shifts whole-body fuel use toward lipid oxidation.\",\n      \"evidence\": \"Pref-1-rtTA lineage tracing/ablation, isoform-specific C2C12 assays, callipyge sheep IHC and transgenic mice, lung cancer overexpression with GSI, and endogenous Dlk1 knock-in metabolic phenotyping\",\n      \"pmids\": [\"25088414\", \"24582655\", \"15498495\", \"24621612\", \"25349437\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How membrane vs soluble isoform ratios are set per tissue unclear\", \"Mechanism of Notch activation in cancer vs Notch-independence in fat unreconciled\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Linked DLK1 to human disease, showing paternally inherited DLK1 deletions cause familial central precocious puberty with hypothalamic expression in kisspeptin neurons.\",\n      \"evidence\": \"Linkage/whole-genome sequencing, segregation, serum DLK1 ELISA, and mouse hypothalamic/kisspeptin expression analysis\",\n      \"pmids\": [\"28324015\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism by which DLK1 sets pubertal timing undefined\", \"Cell-autonomous role in kisspeptin neurons untested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined the Sox9-Meis1 axis maintaining adipose precursors and showed DLK1's soluble domain promotes angiogenesis via Notch1/Akt/eNOS, consolidating Sox9 as the central precursor-maintenance node and Notch as a context-specific effector.\",\n      \"evidence\": \"Inducible Sox9 knockout in Pref-1+ cells with Meis1 manipulation; recombinant DLK1 ectodomain on endothelial cells with DAPT, Notch1 siRNA/antibody, and aortic ring/corneal assays\",\n      \"pmids\": [\"30355480\", \"29383634\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Switch between integrin and Notch signaling modes mechanistically unexplained\", \"Endothelial study single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Confirmed and broadened the human disease link by showing DLK1 frameshift loss-of-function causes precocious puberty co-occurring with obesity, glucose intolerance and PCOS, positioning DLK1 at the reproduction-metabolism interface.\",\n      \"evidence\": \"DNA sequencing, segregation across three families, serum DLK1 ELISA, and metabolic profiling of carriers\",\n      \"pmids\": [\"30462238\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal pathway from DLK1 loss to metabolic disease unmapped\", \"Genotype-phenotype correlation limited\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Extended DLK1 to neural and oncologic contexts, showing biallelic (imprint-escaping) hippocampal expression supports adult neurogenesis and cognition, and that surface DLK1 is a tractable therapeutic target via antibody-drug conjugate in neuroblastoma.\",\n      \"evidence\": \"Allele-specific expression and loss-of-function mouse models with behavioral assays; shRNA knockdown and ADC (ADCT-701) xenograft efficacy in neuroblastoma\",\n      \"pmids\": [\"33712542\", \"39454577\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signaling mechanism in neurogenesis undefined\", \"DLK1 driver vs marker role in neuroblastoma not fully resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular identity of the signaling receptor that transduces soluble DLK1 to MEK/ERK, and the determinants that switch DLK1 between fibronectin/integrin-dependent, intracellular-domain-dependent, and Notch-dependent modes across tissues, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct signaling receptor for the ectodomain identified\", \"Rules governing tissue-specific pathway selection unknown\", \"Mechanism linking ERK/integrin signaling to Sox9 induction undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [12, 17]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 3, 15]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 3, 28]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [2, 3, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [12, 17, 25]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [15, 21, 26]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [23, 6]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"FN1\",\n      \"ITGA5\",\n      \"NOTCH1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"faith_supported":9,"faith_total":9,"faith_pct":100.0}}